9983 — Central China New Life Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.51bn
- -HK$88.76m
- CNY2.84bn
- 68
- 52
- 44
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 308 | 557 | 826 | 759 | -696 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 22.2 | 16.2 | 123 | 74.6 | 1,265 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -63.1 | -318 | -829 | -586 | -695 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 281 | 281 | 178 | 309 | -77.1 |
Capital Expenditures | -14.1 | -21.4 | -28.6 | -15.6 | -12.8 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 658 | -511 | 274 | 142 | 31.3 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 644 | -533 | 246 | 127 | 18.5 |
Financing Cash Flow Items | -42.6 | -71.4 | -7.02 | -17.7 | -9.01 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -474 | 2,004 | -361 | -676 | -370 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 451 | 1,633 | 46.6 | -215 | -429 |